Sai Parenterals544742Quarterly results
Consolidated results for the quarter Ended 30.09.2026
By ScoutQuest · · 1 min read
| Line item | Latest | Year ago | YoY | Prev qtr | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,949.18 | 535.28 | +264% | 1,786.72 | +9.1% |
| Total income | 1,986.37 | 548.63 | +262% | 1,824.13 | +8.9% |
| Profit before tax | 98.89 | 91.54 | +8% | 97.90 | +1% |
| Profit after tax | 105.10 | 63.50 | +65.5% | 79.23 | +32.7% |
| Total comprehensive income | 105.10 | 63.50 | +65.5% | 79.23 | +32.7% |
| Basic EPS | 2.38 | 0.48 | +396% | 1.79 | +33% |
- Total income (latest)
- 1,986.37 million, up 262% YoY vs 548.63 million
- Profit after tax (latest)
- 105.10 million, up 65.5% YoY vs 63.50 million
- PAT growth QoQ
- +32.7% vs prev qtr 79.23 million
- Period
- Quarter Ended 30.09.2026
Also decided at the meeting
- Approved acquisition of remaining 25% equity (2,500 shares of Rs.10/- each, aggregating Rs.25,000/-, cash) in SP Analytics Private Limited, making it a wholly owned subsidiary; completion on or before 31.12.2026.
- Constituted a Management Committee chaired by Managing Director Anil Kumar Karusala.
- Completed acquisition of 60% of equity share capital of Saicriti Pharma Private Limited (approved on August 11, 2026), which became a subsidiary.
Notes to the results
- No exceptional and/or extraordinary items were reported during the quarter ended 30 September 2026.
- The CODM evaluates performance on the basis of a single reportable segment (branded generic formulations and CDMO products and services); no segment-wise disclosure.
Consolidated results for the quarter Ended 30.09.2026.
1,949.18 (₹ in Millions)Revenue from operations, latest quarter
Total income, quarter1,824.13 (₹ in Millions)
Total comprehensive income, quarter79.23 (₹ in Millions)
Total comprehensive income, year-ago quarter63.50 (₹ in Millions)
Also from Sai Parenterals
Sai Parenterals investor presentation: Q2 FY27 revenue jumps on Noumed consolidation as Rs. 571 crore capex builds
1 Nov 2026
Sai Parenterals Ltd press release, Q2 FY27
1 Nov 2026
Q2 FY27 results, buyout of remaining 25% in SP Analytics, Saicriti Pharma deal completed
1 Nov 2026
More numbers
- Total income, latest quarter1,986.37 (₹ in Millions)
- Total income, year-ago quarter548.63 (₹ in Millions)
- Total income, previous quarter1,824.13 (₹ in Millions)
- Total comprehensive income, latest quarter105.10 (₹ in Millions)
- Total comprehensive income, year-ago quarter63.50 (₹ in Millions)
- Total comprehensive income, previous quarter79.23 (₹ in Millions)
- Profit after tax, latest quarter105.10 (₹ in Millions)
- Profit after tax, year-ago quarter63.50 (₹ in Millions)
- Profit after tax, previous quarter79.23 (₹ in Millions)
- Revenue from operations, latest quarter1,949.18 (₹ in Millions)
- Revenue from operations, year-ago quarter535.28 (₹ in Millions)
- Revenue from operations, previous quarter1,786.72 (₹ in Millions)
- Profit before tax, latest quarter98.89 (₹ in Millions)
- Profit before tax, year-ago quarter91.54 (₹ in Millions)
- Profit before tax, previous quarter97.90 (₹ in Millions)
Source: BSE · 1 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.